V
GCVRZ

Veritable’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Veritable’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-53,843
Closed -$25K – 1018
2014
Q3 		$25K Sell
53,843
-360
-0.7% -$175 ﹤0.01% 953
2014
Q2 		$27K Buy
+54,203
New +$26.2K ﹤0.01% 945
2014
Q1 		– Sell
-4,203
Closed -$1K – 1035
2013
Q4 		$1K Buy
+4,203
New +$5.08K ﹤0.01% 981

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Veritable's GCVRZ Position: Q4 2014 in Review

Veritable sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2014, closing a stake of 53,843 shares — an estimated $25K sold.

Veritable first reported a position in GCVRZ in Q4 2013 and held it in 3 quarters. The position peaked at $27K in Q2 2014. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2014.

  • Veritable reported no remaining Sanofi Contingent Value Rights position as of Q4 2014 after selling out during the quarter.
  • Veritable sold 53,843 Sanofi Contingent Value Rights shares in Q4 2014, an estimated $25K.
  • Veritable first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 3 quarters.
  • Veritable's Sanofi Contingent Value Rights position peaked at $27K in Q2 2014.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2014.

Based on Veritable's 13F filing for Q4 2014, filed 17 Feb 2015.